Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy

BACKGROUND: Epigenetic silencing of O(6)-methylguanine-DNA-methyltransferase (MGMT) by promoter methylation is associated with improved survival in glioblastomas treated with alkylating agents. In this study, we investigated MGMT promoter methylation in glioblastomas treated with temozolomide and ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Dunn, J, Baborie, A, Alam, F, Joyce, K, Moxham, M, Sibson, R, Crooks, D, Husband, D, Shenoy, A, Brodbelt, A, Wong, H, Liloglou, T, Haylock, B, Walker, C
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2713697/
https://www.ncbi.nlm.nih.gov/pubmed/19536096
http://dx.doi.org/10.1038/sj.bjc.6605127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2713697/
https://www.ncbi.nlm.nih.gov/pubmed/19536096
http://dx.doi.org/10.1038/sj.bjc.6605127

Ejemplares similares